Assessment of the Clinical, Cellular and Molecular Effects of Royalactin-Royal Jelly on the Healing of Wagner Grad II Diabetic Foot Ulcers.

NCT07509268 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

DRUG: Royalactina
DRUG: Placebo

Sponsor

Universidad Autonoma de Nuevo Leon